Quantitative Analysis of Multiple Subtypes of Immune System Cells in Cancer Tissues

Introduction:

Background

  • The modulation of the immune system holds promise in cancer treatment.
  • Molecular markers allows for reliable identification and subsequent analysis of individual inflammatory cell types and subtypes to profile the immune component of a tissue.
  • Measuring the composition of immune cell types in tumor biopsies can have prognostic value.
  • It is thought that similar approaches can predict patient response to a given therapeutic agent.
  • Establishing a quantitative paradigms for measuring the composition of immune cell types in tumor biopsies is essential for both prognostic and diagnostic approaches.
  • Capturing the quantity and complexity immune infiltration in tumor biopsies requires a whole-tissue based quantitation method capable of integrating multiple inflammatory
    cell markers.
  • In this study, we combined novel advents in tissue image analysis (tIA) to integrate spatial expression of 6 serial-section stained cell-type specific markers in whole tissue clinical
    lung cancer samples.

Study Context & Design

  • Exploratory proof-of-principle study was designed and engineered to demonstrate full spatial integration of immune cell markers in the context of whole tissues and on cell- by-cell basis.
  • Serial sections of clinical lung specimens were generated and IHC was performed for CD68, CD4, CD8, CD33, FoxP3, and CD11b markers.
  • CellMapTM algorithm was utilized to identify and determine the precise location of individual inflammatory cells in tissues on cell-by-cell basis in the tumor microenvironment
    (TME).
  • Flagship’s FACTS™ (Feature Analysis on Consecutive Tissue Sections) approach was used to integrate six markers (CD68, CD4, CD8, CD33, FoxP3 ,and CD11b )in individual cells onto nascent architecture of the tissue using H&E slides.
  • Flagship’s MultivariateMap™ was used to integrate the inflammatory cell types recorded by the 6 markers based on their function and role in immune system biology.
  • Using Flagship’s proprietary image analysis tools, we show utility of Flagship’s tIA approaches for pro ling individual inflammatory cell types and providing a comprehensive landscape of the immune system state in tissue biopsies.
  • Integrating spatial information of immune cell marker expression will benefit further understanding of cancer pathology and the development of diagnostic tests with clinical value.

Conclusions:

  • IHC Staining followed by application of Flagship’s proprietary CellMap™ algorithm allows cell-by-cell quantification and localization of the cells in whole tissues.
  • FACTS™ integrates the spatial expression of individual markers onto a reference H&E slide, and/or adjacent slides.
  • MultivariateMap™ integrates the patterns of each marker based on immune cell type function and allows the visualization and measurement of multiple cell subtypes in the same tissue.
  • These approaches avoid difficult-to-implement wet assay strategies involving multiplexing 6 markers on the same section which are difficult to implement in the diagnostic setting needed to support patient selection strategies.

Flagship’s proprietary image analysis approaches provide a robust platform for immuno-oncology applications by providing information on the state of the immune system in cancer using approaches implementable in the clinic.